The treatment, the first of its kind, was approved by the Food and Drug Administration on Thursday. “Our baby was born deaf, ...

The Food and Drug Administration on Thursday approved Regeneron’s Otarmeni, the first gene therapy for genetic hearing loss ...

The US Food and Drug Administration on Thursday approved the first gene therapy for inherited hearing loss, a one-time ...

Researchers confirm gene therapy can reverse inherited deafness, offering hope to millions born with genetic hearing loss ...

The U.S. ‌Food and Drug Administration has approved Regeneron's gene therapy for ​a rare genetic form ​of deafness, the ...

Researchers say a gene therapy allowed deaf children and adults as old as 32 to hear for the first time. The benefits have ...

A new gene therapy tested in China has improved the hearing of 38 people who were born deaf due to mutations in a gene called ...

Molecular biologist Jean Bennett and ophthalmologist Albert Maguire were awarded the $3 million Breakthrough Prize in Life ...

Three scientists have won the 2026 Breakthrough Prize for developing Luxturna — the world's first FDA-approved gene therapy ...

The treatment, developed by Regeneron Pharmaceuticals, is for a very rare form of deafness. But it represents a medical ...

Two Philadelphia doctors who led the groundbreaking gene-editing treatment of baby boy from Delaware County are included ...

Eli Lilly boosts genetic medicine capabilities with Kelonia acquisition, strengthening innovation and precision therapy ...